top of page

The FUSE platform

Revolutionizing gene therapy with revolutionary cell-free viral vector technology

Fuse website (2).png

Fuse Technology

Under the tag line: “Catalyzing Gene Therapy - Revolutionary therapies need revolutionary technology” we are developing our novel Fuse Technology aiming at designing, making and delivering ideal AAVs for gene therapy.

Fuse website (1).png

Fuse Foundry

Our enzymatic filling is modular, where components are stored in a “Fuse Foundry” library, enabling rapid production and scalability.

Fuse website.png

Fuse Optimization Engine

The ability to "Build, Test, and Learn" through multi-parallel prototyping with the "Fuse Optimization Engine" enables the production of the best performing AAV drug product.

The "Fuse Vector"

Traditional Adeno-Associated Viral (AAV) vectors produced with cell-based methods face inefficiency, high toxicity, and costly production. Our "Fuse Technology" offers superior alternative by creating "Fuse Vectors"

Partner with us

FInd out more about how you can utilize our technology platform

Our pipeline

Learn more about how we use the Fuse platform for our internal drug pipeline development

bottom of page